Par Pharmaceutical Companies, Inc. (NYSE:PRX)

CAPS Rating: 3 out of 5

The Company, through its subsidiary Par Pharmaceutical, Inc., is engaged in the development, manufacture and distribution of generic pharmaceuticals and branded pharmaceuticals in the United States.

Recs

0
Player Avatar TALICAS101 (< 20) Submitted: 1/19/2010 8:40:58 PM : Outperform Start Price: $27.09 PRX Score: +35.31

Drugs Pick

Featured Broker Partners


Advertisement